Up-regulated MRPS23 had a worse OS in of glioma subgroups, including gender, IDH status (WT), 1p/19q codeletion (non-codel), histological type (astrocytoma), age (<=60), race (white) (Figure 9B). This evidence concerns the gene MRPS23 and central nervous system cancer.